Top Dapoxetine Brands: A Guide to Leading Choices

Dapoxetine is a popular medication used primarily to treat premature ejaculation in men, and it is available under various brand names around the world. As with any medication, choosing the right brand can be vital for effectiveness and affordability. Some of the top brands for dapoxetine include Priligy, Duratia, and Super P-Force, each known for their quality and reliability. These brands have gained recognition for their consistency in delivering results and are often recommended by healthcare professionals. For a more detailed list of the best dapoxetine brands, explore the information provided below.

Illustration of dapoxetine

Best brands of dapoxetine in 2025

Priligy

Priligy, marketed by companies like Janssen-Cilag AB, is a leading brand for dapoxetine, a selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation in men aged 18-64. Dapoxetine, the active ingredient in Priligy, is available in 30 mg and 60 mg tablets and works by increasing serotonin levels, thereby delaying ejaculation. Approved in over 50 countries, including Italy, Spain, and Mexico, Priligy has been on the market since 2009, with its marketing authorization extended to multiple European countries through the mutual recognition procedure. The drug has a bioavailability of 42% and is metabolized primarily by the liver and kidneys. Priligy is known for its fast-acting properties, making it suitable for treating premature ejaculation.

Super P-Force

Super P-Force, manufactured by Sunrise Remedies Pvt. Ltd., is a highly effective medication that combines 100mg of Sildenafil and 60mg of Dapoxetine, addressing both erectile dysfunction and premature ejaculation. This dual-action tablet enhances blood flow and delays ejaculation, significantly improving sexual satisfaction. Dapoxetine, a serotonin-norepinephrine reuptake inhibitor, increases serotonin levels to delay the ejaculation reflex, reducing personal distress associated with premature ejaculation. The medication is contraindicated for patients with certain health conditions, such as heart problems, severe liver and kidney impairment, and those taking specific medications like nitrates and monoamine oxidase inhibitors. It is crucial to follow the prescribed dosage to avoid serious side effects. For more details on purchasing options, visit the official Super P-Force online store.

Sustinex

Sustinex, a prominent brand for dapoxetine, is recognized for its high-quality formulation and efficacy in treating premature ejaculation. Dapoxetine, marketed under brands like Sustinex, is a selective serotonin reuptake inhibitor (SSRI) with a mean bioavailability of 42% and a terminal half-life of 18.7 to 21.9 hours depending on the dose. The drug is absorbed and distributed rapidly, with over 99% bound to plasma proteins, making it a fast-acting solution for men aged 18-64 years. The market for dapoxetine, including brands like Sustinex, is expected to grow at a CAGR of 10.2% from 2024 to 2031, reaching a market size of USD 1.8 billion by 2031. This growth is driven by increasing prevalence and awareness of premature ejaculation.

Duratia

Duratia, manufactured by Sunrise Remedies, is a prominent brand for dapoxetine, a selective serotonin reuptake inhibitor used to treat premature ejaculation. The recommended dose of Duratia is 30mg, which can be adjusted by a physician. Dapoxetine has shown efficacy in increasing the time to ejaculation, with a bioavailability of 15-76% and a mean steady-state volume of 162 L. The drug has been approved in over 50 countries, including Italy, Spain, and Mexico, and is expected to drive market growth with a projected CAGR of 10.2% from 2024 to 2031. Duratia's effectiveness and widespread approval make it a significant player in the dapoxetine market.

Dapoxetine HCl

Dapoxetine HCl, marketed under the brand name Priligy among others, is a highly effective treatment for premature ejaculation, developed and initially submitted for FDA approval by Eli Lilly and later managed by Johnson & Johnson. It has been approved in over 50 countries, including Italy, Spain, Mexico, and New Zealand, and is distributed by various companies such as Menarini and Berlin-Chemie. The drug exhibits rapid absorption and distribution, with greater than 99% bound to plasma protein, and has a terminal half-life of approximately 18-22 hours depending on the dose. Priligy has demonstrated bioequivalence in 30 mg and 60 mg tablets, ensuring consistent efficacy. Its widespread approval and distribution underscore its position as a leading treatment in its class. For more detailed information, you can explore the International Dapoxetine Information.

Fortune Health Care

Fortune Health Care is a reputable manufacturer, supplier, and exporter of a wide range of pharmaceutical medications, including dapoxetine, which is used to treat premature ejaculation. Known for their clinically tested and dependable components, Fortune Health Care ensures high-quality products. While specific data on their dapoxetine production is not provided, their extensive selection and reliable reputation make them a trusted name in the industry. Fortune Health Care offers various other pharmaceutical products, including erectile dysfunction tablets, skin care capsules, and pain relief medicines. Their commitment to quality and customer satisfaction has established them as a leading brand in the pharmaceutical sector.

Sunrise Remedies

Sunrise Remedies, an ISO 9001:2015 certified company, is a leading manufacturer of premium pharmaceuticals, including dapoxetine, a selective serotonin reuptake inhibitor used for treating premature ejaculation. With a WHO and GMP certified manufacturing plant, Sunrise Remedies ensures high-quality products. Established in September 2019, the company has quickly gained a strong presence in the international market with brands like Priligy equivalents. Their products, such as Poxet and others, are known for their efficacy and safety, with dapoxetine exhibiting a bioavailability of 15-76% and a rapid elimination half-life of 1.31 to 1.42 hours.

Ajanta Pharma

Ajanta Pharma is a leading pharmaceutical company, particularly notable for its strong presence in the branded generics market, including products like dapoxetine. The company has a diversified geographical presence, with 73% of its business coming from branded generics, and it has achieved significant growth in various therapeutic segments. In FY 2022, Ajanta Pharma launched 16 new products, including four that were first to market, and its Indian business contributed 30% of the total revenue. The company's emerging markets, including Asia and Africa, saw a 24% growth in exports, reaching Rs1,400 crore. Ajanta Pharma's robust supply chain ensures consistent product availability across its markets.

Cipla

Cipla, a leading pharmaceutical company, has demonstrated significant prowess in producing dapoxetine, a selective serotonin reuptake inhibitor used for treating premature ejaculation. In FY23, Cipla reported robust growth across its focused markets, including a 27% year-over-year (YoY) growth in its US business, driven by key launches and market share expansion. The company's strong R&D investments, standing at 6.5% of sales, have been crucial in advancing clinical trials for key pipeline assets. Cipla's commercial portfolio, with 55% of its products ranking in the top three in market share, underscores its commitment to quality and innovation. This growth momentum is expected to continue, with Cipla deepening its leadership in branded markets and expanding its differentiated pipeline. For more detailed information, visit Cipla's official website.

Sun Pharmaceutical Industries

Sun Pharmaceutical Industries, one of the leading pharmaceutical companies globally, is notable for its extensive portfolio of generic and specialty drugs, including dapoxetine. As the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company worldwide, Sun Pharma has a significant presence in over 100 countries. The company's revenue is largely driven by international markets, with around 70% generated from outside India. Sun Pharma's acquisition of Ranbaxy in 2015 further solidified its position, making it a major player in the global pharmaceutical market. However, specific details on Sun Pharma's production and marketing of dapoxetine are not widely highlighted, as dapoxetine is primarily associated with other pharmaceutical companies like Johnson & Johnson and Menarini. For more comprehensive insights, you can visit Sun Pharma's Wikipedia page.